InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
8
T+90 hit rate
64%
T+90 mean return
+4.9%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by PISKEL KYLE, Responsable Comptable Principal. Insider active across 1 company, notably Adaptive Biotechnologies Corp. In total, 22 disclosures have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €3m. History available since 15 November 2021. The latest transaction was disclosed on 11 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations22 total
18,672 shares@ US$13.175.1% of flowCommon StockSEC:0001780662-26-000006:0
61,875 shares0Common StockSEC:0001780662-26-000004:0
2,145 shares@ US$12.140.5% of flowCommon StockSEC:0001780662-26-000002:0
4,290 shares@ US$12.141.1% of flowCommon StockSEC:0001780662-26-000001:0
11,980 shares@ US$6.551.8% of flowCommon StockSEC:0001780662-25-000003:0
3,750 shares@ US$7.800.7% of flowCommon StockSEC:0001780662-25-000003:1
94,384 shares@ US$12.1425.6% of flowCommon StockSEC:0001780662-25-000003:2
162,820 shares@ US$19.5070.8% of flowCommon StockSEC:0001780662-25-000003:3
238 shares@ US$14.050.1% of flowCommon StockSEC:0001780662-25-000002:0
1,929 shares@ US$8.890.4% of flowCommon StockSEC:0001062993-25-009904:0
7,815 shares0Common StockSEC:0001062993-25-009837:0
2,500 shares@ US$6.320.4% of flowCommon StockSEC:0001062993-25-005645:0
125,000 shares0Common StockSEC:0001062993-25-004813:0
248 shares@ US$4.980.0% of flowCommon StockSEC:0001062993-24-019373:0
31,260 shares0Common StockSEC:0001062993-24-010709:0
43,740 shares0Common StockSEC:0001062993-24-005768:0
259 shares@ US$4.130.0% of flowCommon StockSEC:0001062993-23-021224:0
43,735 shares0Common StockSEC:0001062993-23-006330:0
307 shares@ US$8.870.1% of flowCommon StockSEC:0001209191-22-057531:0
959 shares@ US$8.870.2% of flowCommon StockSEC:0001209191-22-057432:0
41,186 shares0Common StockSEC:0001209191-22-017396:0
3,837 shares0Common StockSEC:0001209191-21-065312:0
22 of 22 declarations
About PISKEL KYLE
Kyle Piskel is the Principal Accounting Officer of Adaptive Biotechnologies Corp. He oversees the company's accounting operations, ensuring compliance with accounting standards and the accuracy of financial reporting. His role is essential in maintaining financial transparency and supporting the company's strategic objectives.
